Pinak Shah, MD
Interventional Cardiology · Boston, MANPI 1750371480
Payments from drug & device makers
Across 484 payments — averaging $6099.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$2.3M
- Abbott$591K
- Shockwave Medical, Inc$61K
- Medtronic$11K
- Boston Scientific$3K
- Philips North America LLC$685
- plus $435 from 7 others
Across 7 payments — averaging $5321.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$36K
- Neovasc Medical Inc$1K
What the payments were for
- Consulting fees$108,33974%
- Speaking & faculty fees$15,85811%
- Travel & lodging$14,22710%
- Food & beverage$8,2356%
- Education$1920%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 362 | $2,283,743 |
| Abbott | 83 | $591,223 |
| Shockwave Medical, Inc | 8 | $61,479 |
| Medtronic(2 entities) | 12 | $11,159 |
| Boston Scientific | 7 | $3,493 |
| Philips North America LLC | 4 | $685 |
| Merit Medical Systems Inc | 1 | $200 |
| Heartflow, Inc. | 1 | $97 |
| Stryker | 2 | $56 |
| Cardiovascular Systems Inc. | 1 | $29 |
| Cardiva Medical, Inc. | 1 | $22 |
| Inari Medical, Inc. | 1 | $17 |
| Teleflex LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$66,953
- GENERAL - THERAPIES$3,121
- TENDYNE$952
- SAPIEN 3 Ultra RESILIA$849
- Mitra Clip system$710
- (9520) IGT Devices Undivided$364
- Tricuspid Valve Repair System$281
- IGT Devices Und$236
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$229
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$190
- NAVITOR$150
- GENERAL VASCULAR ACCESS$146
- COREVALVE EVOLUT R$135
- XIENCE SIERRA$106
How this compares
$2,952,218 in reported general payments places this provider in the 95th percentile of 128 interventional cardiology providers in Massachusetts.
See all interventional cardiology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 34 | $35,540 |
| Rosuvastatin Calcium | 40 | $1,168 |
| Metoprolol Succinate | 53 | $1,069 |
| Ezetimibe | 27 | $838 |
| Atorvastatin Calcium | 30 | $509 |
| Amlodipine Besylate | 26 | $252 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 15 | $239 |
| Furosemide | 32 | $139 |
| Losartan Potassium | 12 | $128 |
| Lisinopril | 16 | $73 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Boston
- Charles GibsonBoston$16.3M
- Eric SecemskyBoston$7.3M
- Duane PintoBoston$4.2M
- Suzanne BaronBoston$3.9M
- Robert YehBoston$2.1M
- Jeffrey PopmaBoston$1.9M
- Roger LahamBoston$1.2M
- Farouc JafferBoston$900K
- Darshan DoshiBoston$838K
- Nicola MaschiettoBoston$540K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.